The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial

Matthew A. Roberts, Helen L. Pilmore, Francesco L. Ierino, Sunil V. Badve, Alan Cass, Amit X. Garg, Nicole M. Isbel, Henry Krum, Elaine M. Pascoe, Vlado Perkovic, Anish Scaria, Andrew M. Tonkin, Liza A. Vergara, Carmel M. Hawley, Adeera Levin, David Hare, Andrew Martin, David C. Wheeler, Gregory Fulcher, Helen BrownDavid Colquhoun, Dariusz Korczyk, Amanda Mather, Andrew Wong, Matthew Roberts, Francesco Ierino, Pascal Bisscheroux, Alastair Gillies, Leanne Garvey, Ken Soon Tan, Erica Lennan, Nicole Isbel, Markus Pitkin, Karin Ahearn, Robert P. Carroll, Eileen Scott, Bruce Cooper, Jacqueline Pearse, Paul Snelling, Jenny Burman, Samantha Hand, Eugenie Pedagogos, Connie Karschimkus, Helen Pilmore, Andrew Pilmore, Robert Walker, Gaye Ellis, Mark R. Marshall, Cecilia Paul, Carmel M. Hawley, David Johnson, Sunil Badve, Alan Cass, Jean Helyar, Alicia Morrish, Elaine M. Pascoe, Peta Anne Paul-Brent, Donna Reidlinger, Liza A. Vergara, Lei Zhang, BLOCADE Study Collaborative Group

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences